The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)

Survival-inferred fragility index of FDA-approved cancer drugs using surrogate endpoints.

Jonathan  Ofer

No Relationships to Disclose

Shai  Gilboa

No Relationships to Disclose

Yarden  Pras

No Relationships to Disclose

Gal  Markel

Stock and Other Ownership Interests  - 4C BioMed; Biond Biologics; Ella Therapeutics; Nucleai; Purple Biotech

Consulting or Advisory Role - 4C BioMed; Beyond Air; Biond Biologics; Ella Therapeutics; Merck Sharp & Dohme; Nucleai; Purple Biotech; Sanofi; Staburo GmbH

Research Funding - Bristol-Myers Squibb; Novartis

David  Bomze

No Relationships to Disclose

Tomer  Meirson

Consulting or Advisory Role - Purple Biotech